- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0012852

About Raghava Life Sciences Private Limited
Data last updated:
Raghava Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC121553. Its GSTIN is 36AAICR6963N1ZJ (Telangana).
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹40 Cr. It is led by directors Sapni Reddy Ponguleti and Lohith Reddy Ponguleti.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.14 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹8.52 Cr (net margin -18.9%) and EBITDA of ₹5.18 Cr (EBITDA margin 11.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 31% over five years.
The company has about 322 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Raghava Life. As per MCA filings, the company has open charges of ₹52.18 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 4 cases are pending. The company has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹39.99 Cr; the latest was in September 2026. Its 6 peer companies in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Amara Labs Private Limited with revenue of ₹45.37 Cr.
Raghava Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0012852). For more details, the company can be reached via its website raghavalife.com.
Company details
Recognitions & Rankings of Raghava Life Sciences
Contact details
Raghava Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is raghavalife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressRaghavapride H.No.8 – 2 – 603/1/27&28 Krishnapuramkrishnapuramstreet Roadno.10 Banjara, Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Raghava Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Raghava Life Sciences operates one associated brand: Raghava Life. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides CRO and CDMO services for pharmaceutical APIs and intermediates globally. | raghavalife.com |
Business activity
The main business activity of Raghava Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Raghava Life Sciences Private Limited, buy the company report.
Financials of Raghava Life Sciences Private Limited
FY 2025 filings availableRaghava Life Sciences Private Limited reported revenue of ₹45.14 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 31%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.5% | ||||
| Net Profit Margin | -18.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raghava Life Sciences Private Limited, buy the company report.
Board of directors of Raghava Life Sciences Private Limited
Raghava Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sapni Reddy Ponguleti | Director | 02 Jan 2018 | 8 Years 9 Months | Current |
| Lohith Reddy Ponguleti | Director | 02 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Raghava Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amara Labs Private Limited | ₹45.37 Cr (FY 2021) | 173.0% | Hyderabad, Telangana, India | |||
| Concord Drugs Limited | ₹45.26 Cr (FY 2025) | 1.0% | Telangana, India | |||
| Raghava Life Sciences Private Limitedthis company | ₹45.14 Cr (FY 2025) | -₹8.52 Cr | -18.9% | -26.0% | 322 | Hyderabad, Telangana, India |
| S.V.Chem Intermediates Private Limited | ₹44.99 Cr (FY 2025) | -11.0% | Thiruporur, Tamil Nadu, India | |||
| FR Chem Private Limited | ₹44.47 Cr (FY 2025) | 59.0% | Ahmedabad, Gujarat, India | |||
| Unidrug Innovative Pharma Technologies Limited | ₹44.46 Cr (FY 2025) | 28.0% | Indore, Madhya Pradesh, India | |||
| S.V.R. Laboratories Private Limited | ₹44.45 Cr (FY 2025) | -3.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Raghava Life Sciences Private Limited, buy the company report.
Auditor
Raghava Life Sciences Private Limited is audited by VAMSI SAI KRISHNA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VAMSI SAI KRISHNA & CO | FY 2023 | 024528S |
Shareholding
The shareholding of Raghava Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Raghava Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Aug 2023 | 100781235 | Axis Bank Limited | ₹9 Lakh | Open | |
| 18 Dec 2021 | 100532462 | Axis Bank Limited | ₹52.09 Cr | Open |
To see the full charge records of Raghava Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Raghava Life Sciences Private Limited has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹39.99 Cr; the latest was in September 2026.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2026 | Acquisition | ₹135 Cr | Buyer: RPG Active Pharma Limited Seller: Raghava Life Sciences Private Limited |
| Dec 2020 | Funding round | ₹39.99 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Raghava Life Sciences Private Limited has 6 court cases on record: 6 filed against it. 4 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 3 |
| High courts | 1 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by M/S Bharat Jyoti Impex Through Ranjay Pandurang Patil | Pending |
| High Court, TELANGANA | Court case (CRLP) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by an individual | Disposed |
To see the full case history of Raghava Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Raghava Life Sciences Private Limited was last rated by Icra on 01 Feb 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 01 Feb 2021 |
To see the full credit ratings and regulatory alerts of Raghava Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raghava Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Raghava Life Sciences Private Limited has a workforce of 322 employees on its EPFO records as of Dec 19, 2024, across 1 active EPFO establishment.
GST
Raghava Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICR6963N1ZJ | Telangana | Active | 19 Feb 2018 |
To see the full GST registrations and return filing status of Raghava Life Sciences Private Limited, buy the company report.
Recent activity
Raghava Life Sciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Lohith Reddy Ponguleti was appointed as Director on 02 Jan 2018.
News
Frequently asked questions
Raghava Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2018 (8+ years old) and is registered under CIN U74999TG2018PTC121553.
Raghava Life Sciences has 2 current directors:
- Sapni Reddy Ponguleti - Director
- Lohith Reddy Ponguleti - Director
The latest financial statements of Raghava Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Raghava Life Sciences is 36AAICR6963N1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Raghava Life Sciences is U74999TG2018PTC121553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raghava Life Sciences has 6 court cases on record: 6 filed against it. 4 are pending. Most are in the district courts.
Raghava Life Sciences was incorporated on 02 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Raghava Life Sciences has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹39.99 Cr; the latest was in September 2026.
The peers of Raghava Life Sciences by revenue are Amara Labs Private Limited, Concord Drugs Limited, S.V.Chem Intermediates Private Limited, FR Chem Private Limited, Unidrug Innovative Pharma Technologies Limited and 1 more, all in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lohith Reddy Ponguleti was appointed as Director on 02 Jan 2018. Sapni Reddy Ponguleti was appointed as Director on 02 Jan 2018.
Yes, Raghava Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0012852).